Placebo to prednisone
Sponsors
Novartis Pharma AG, Celgene
Conditions
+/- VLupus Nephritis Class III-IVMyelofibrosisMyelofibrosis With Myeloid MetaplasiaMyeloid Metaplasia
Phase 2
A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia
CompletedNCT00463385
Start: 2007-04-01End: 2013-12-31Updated: 2019-11-20
An adaptive, randomized, double-blind, dose exploration, parallel group, placebo controlled, multicenter phase 2 trial to evaluate the efficacy, safety and tolerability of LNP023 in combination with standard-of-care with and without oral corticosteroids in adult patients with active lupus nephritis Class III-IV, +/- V
RecruitingCTIS2023-509332-26-00
Start: 2023-02-16Target: 48Updated: 2025-12-30